Volume 11 (2011) - September 2011
Lawrence K Leung, Francis M Patafio, Walter W Rosser BMC Clinical Pharmacology 2011, 11:15 (28 September 2011)
Evidence from published randomized controlled trials indicates that the smoking cessation aid varenicline is associated with major gastrointestinal adverse effects at maintenance dose of 1 mg twice a day for longer than 6 weeks.
Marie-Louise Johansson, Staffan Hägg, Susanna M Wallerstedt BMC Clinical Pharmacology 2011, 11:14 (7 September 2011)
Repeated distribution of adverse drug reaction (ADR) information letters fails to increase the ADR reporting rate in Swedish primary healthcare units, though the number of high quality reports detailing serious or unexpected reactions does increase.